Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Solas

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
AIDS (London, England)|April 14, 2009
Etravirine-raltegravir, a marked interaction in HIV-1-infected patients: about four casesAmélie Ménard, Caroline Solas, Saadia Mokthari, et al.
Clinical Toxicology (Philadelphia, Pa.)|January 27, 2025
Presence of sibutramine and sildenafil in weight loss dietary supplements: a case series with analytical and clinical investigationMarie Carles, Tessa Pietri, Joelle Micallef, et al.
Drug Testing and Analysis|January 3, 2023
Determination of cannabinoids content in light cannabis inflorescences sold in FranceNicolas Fabresse, Marc Faltot, Perrine Roux, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 1, 2012
Renal impairment in patients receiving a tenofovir-cART regimen: impact of tenofovir trough concentrationIsabelle Poizot-Martin, Caroline Solas, Julie Allemand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimenCaroline Solas, Stéphanie Basso, Isabelle Poizot-Martin, et al.
Therapeutic Drug Monitoring|November 9, 2020
Development and Validation of a Simple and Rapid Ultrahigh-Performance Liquid Chromatography Tandem Spectrometry Method for the Quantification of Hydroxychloroquine in Plasma and Blood Samples in the Emergency Context of SARS-CoV-2 PandemicNatalia Doudka, Madeleine Giocanti, Manon Basso, et al.
British Journal of Clinical Pharmacology|October 14, 2017
Ledipasvir and tenofovir drug interaction in human immunodeficiency virus-hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safetyCaroline Solas, Sylvie Bregigeon, Olivia Faucher-Zaegel, et al.
Critical Care (London, England)|September 22, 2011
Effect of fluid loading during hypovolaemic shock on caspofungin pharmacokinetic parameters in pigAntoine Roch, Christian Woloch, Dorothée Blayac, et al.
Journal of Medical Virology|September 22, 2012
Lack of benefit of 3-month intensification with enfuvirtide plus optimized background regimen (OBR) versus OBR alone in patients with multiple therapeutic failures: the INNOVE studyLaurence Morand-Joubert, Jade Ghosn, Constance Delaugerre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2016
First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than EverAmélie Menard, Philippe Colson, Dhiver Catherine, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
AIDS (London, England)|April 14, 2009
Etravirine-raltegravir, a marked interaction in HIV-1-infected patients: about four casesAmélie Ménard, Caroline Solas, Saadia Mokthari, et al.
Clinical Toxicology (Philadelphia, Pa.)|January 27, 2025
Presence of sibutramine and sildenafil in weight loss dietary supplements: a case series with analytical and clinical investigationMarie Carles, Tessa Pietri, Joelle Micallef, et al.
Drug Testing and Analysis|January 3, 2023
Determination of cannabinoids content in light cannabis inflorescences sold in FranceNicolas Fabresse, Marc Faltot, Perrine Roux, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 1, 2012
Renal impairment in patients receiving a tenofovir-cART regimen: impact of tenofovir trough concentrationIsabelle Poizot-Martin, Caroline Solas, Julie Allemand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimenCaroline Solas, Stéphanie Basso, Isabelle Poizot-Martin, et al.
Therapeutic Drug Monitoring|November 9, 2020
Development and Validation of a Simple and Rapid Ultrahigh-Performance Liquid Chromatography Tandem Spectrometry Method for the Quantification of Hydroxychloroquine in Plasma and Blood Samples in the Emergency Context of SARS-CoV-2 PandemicNatalia Doudka, Madeleine Giocanti, Manon Basso, et al.
British Journal of Clinical Pharmacology|October 14, 2017
Ledipasvir and tenofovir drug interaction in human immunodeficiency virus-hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safetyCaroline Solas, Sylvie Bregigeon, Olivia Faucher-Zaegel, et al.
Critical Care (London, England)|September 22, 2011
Effect of fluid loading during hypovolaemic shock on caspofungin pharmacokinetic parameters in pigAntoine Roch, Christian Woloch, Dorothée Blayac, et al.
Journal of Medical Virology|September 22, 2012
Lack of benefit of 3-month intensification with enfuvirtide plus optimized background regimen (OBR) versus OBR alone in patients with multiple therapeutic failures: the INNOVE studyLaurence Morand-Joubert, Jade Ghosn, Constance Delaugerre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2016
First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than EverAmélie Menard, Philippe Colson, Dhiver Catherine, et al.
Pageof 13